Umoja Biopharma | $100,000,000 | (Jan 21, 2025)
Fundment | $55,157,175 | (Jan 21, 2025)
r4 | $1,000,000 | (Jan 21, 2025)
Thyme Care
United States
- Nashville, TN
- 22/08/2023
- Series B
- $60,000,000
Thyme Care is a value-based oncology management platform whose mission is to improve the quality of life for people diagnosed with cancer by providing personalized, clinically coordinated care. Thyme Care pairs human guidance with software and analytics to quickly connect members to the right care and provide ongoing support through targeted, evidence-based interventions. Founded by oncology industry veterans and clinicians, the company's approach prioritizes deep provider relationships and integrates with a health plan’s existing infrastructure, coordinating value-driven care that leads to better outcomes, lower costs, and an improved member experience. Backed with venture funding from Andreessen Horowitz (a16z), AlleyCorp, Frist Cressey Ventures, Casdin Capital, and Bessemer, Thyme Care partners with health insurance plans and providers to extend the reach of high-quality cancer care through flexible value-based payment arrangements, including risk-based programs. To learn more about how Thyme Care is unlocking high-value care in oncology, visit www.thymecare.com.
- Industry Hospital & Health Care
- Website https://www.thymecare.com/
- LinkedIn https://www.linkedin.com/company/thymecare/about/
IntusCare | $11,500,000 | (Jan 21, 2025)
Alteva Technologies | $1,760,526 | (Jan 21, 2025)
ecoplanet | $16,571,680 | (Jan 21, 2025)
StepChange.work | $4,000,000 | (Jan 21, 2025)
Sereact | $25,894,660 | (Jan 21, 2025)
Men In Blazers Media Network | $150,000,000 | (Jan 21, 2025)
Pipe17 | $15,500,000 | (Jan 17, 2025)
Coram AI | $13,800,000 | (Jan 17, 2025)
Quantifind | $22,000,000 | (Jan 17, 2025)